AAAAAA

   
Results: 1-21 |
Results: 21
ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN
Authors: KEREIAKES DJ BERKOWITZ SD ANDERSON K SIMOONS M VAHANIAN A LINCOFF AM TCHENG JE WEISMAN H CALIFF RM TOPOL EJ
Citation: Dj. Kereiakes et al., ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 55-55
PHARMACODYNAMICS OF REOPRO (C7E3 FAB) - FREE PLASMA-LEVELS DETERMINE CLINICAL EFFICACY
Authors: WAGNER C MACE K MASCELLI MA DERITA R LANCE E WEISMAN H GHRAYEB J JORDAN R
Citation: C. Wagner et al., PHARMACODYNAMICS OF REOPRO (C7E3 FAB) - FREE PLASMA-LEVELS DETERMINE CLINICAL EFFICACY, Thrombosis and haemostasis, 1997, pp. 26-26
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ABCIXIMAB BEFORE AND DURING CORONARY INTERVENTION IN REFRACTORY UNSTABLE ANGINA - THE CAPTURE STUDY
Authors: SIMOONS ML RUTSCH W VAHANIAN A ADGEY J MASERI A VASSANELLI C COL J ADELMAN A MACAYA C MILLER H DEBOER MJ MCCLOSKEY R WEISMAN H VERSTRAETE M DEBONO D SWEDBERG K LESSAFRE E SCHOTSMANS P TIJSSEN J BAR F DECKERS JW PIEK JJ KLOOTWIJK APJ BLOCK P CATS VM BRUGGELING W JONKMAN F VANDERMEER P UMANS V FOLEY D ANSINK T KEANE D SANE D KOUDSTAAL P VANDENBRAND MJBM LAARMAN GJ HENDRICKX G DESCHEERDER I STEG PG BEATT K VANPAPENDRECHT MH LENDERINK T MALBRAIN S PAUL J DECRAEN T CABACOWIC S SCHAIBLE T ANDERSON K WANG A FITZPATRICK S DANIELS M POULUSSEN T DEGRAFF J DIJKHUIZEN M VERHAMME K NELISSEN I GIBBS M MARRON S LOCHU S GUIOT C FERRARI P VIZZOTTO A ALEMANY A MALTILLO E HOFFMANN S STAHL L KAFKA D SURYAPRANATA H LIEM AL VELSINK G VANDERWIEKEN R EZECHIELS JP ZONNEVELD S VANDENBRAND M VANDERZWAAN C KINT PP MICHELS RM BONMIER J VANDERKERKHOF I HANEKAMP C PEELS J DROK L DENHEIJER P PLOKKER T MAST EG MARQUEZ K VANDENBOS AA CHIN U CORNEL JH ARNOLD A GARBARZ E NALLET O FARRAH B CARRIE D PUEL J JEAN M CHARBONNIER B PACOURET G RAYNAUD R BERTRAND B VANZETTO G GROLLIER G VALETTE B THERY C LABLANCHE JM DUCLOS F COSTE P BEAUFILS P EIFERMAN E DAUBERT C LECLERCQ C JULIARD JJM BASSAND JP MENEVEAU N GUERMONPREZ JL VROLIX M VANLIERDE J JACOBS S BOLAND J SAAT G BAUMANS P STAELENS F DEBRUYNE B TAEYMANS Y GHEERAERT P ALSCHWAFI K VANDENHEUVEL P ROGIERS R CASTADOT M DEWIT E GULBA D DECHEND R CHRISTOW S SIMON R ALMOKTHARI N VONDAHL J JANSSENS U HAUDE M BAUMGART D KARSCH KR MAIER R BRUNCKHORST C REIFART N KRAJCAR M RUPPRECHT HJ COBAUGH M HERNANDEZANTOLIN R SEGOVIA J GARCIA P CEQUIR A ESPLUGAS E GOMEZHOSPITAL J MAURI J ANGEL J BALLESTER R DELATASSA CM BARRIALES F AUGE J GARCIA J MELGARES R KHAN M JOHNSTON P MCKAY Y BEEN M KAHN A ILSLEY C EWAN A REID D MCDERMOTT A WARD D BULLER N BALCON R ZARDINI P LOSCHIAVO I CASARI A PITI A COSTALUNGA A REPETTO S CARELLA S MARZILLI M FEDELE S CHIOIN R REIMERS B MAZZARI A SPECCHIA G CHIARIELLO M SHEPPS D SCLAROVSKI S GAL B CASPI A AYZENBERG O SHARIR T HOD H BUSER P PFISTERER M RITZ R BERTEL O ROHNER F DUCAS J SHICK U CHEUNG P CHISHOLM R COHEN E GOMEZ RS FERREIRA J MUHLBERGER V
Citation: Ml. Simoons et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ABCIXIMAB BEFORE AND DURING CORONARY INTERVENTION IN REFRACTORY UNSTABLE ANGINA - THE CAPTURE STUDY, Lancet, 349(9063), 1997, pp. 1429-1435
EVOLUTION OF THE CLINICAL-APPLICATIONS OF GLYCOPROTEIN IIB INHIBITORS- AMELIA-ISLAND, FLORIDA - JULY 21-23, 1995 - ROUND-TABLE PANEL DISCUSSION
Authors: LINCOFF AM FERGUSON JJ POPMA J WEISMAN H AGUIRRE F",TCHENG,"SCOTT R SHAW R",MUHLESTEIN,"IVANHOE R",HILLEGAS,"ARNOLD A
Citation: Am. Lincoff et al., EVOLUTION OF THE CLINICAL-APPLICATIONS OF GLYCOPROTEIN IIB INHIBITORS- AMELIA-ISLAND, FLORIDA - JULY 21-23, 1995 - ROUND-TABLE PANEL DISCUSSION, The Journal of invasive cardiology, 8, 1996, pp. 62-80
EFFECT OF SINUS DENERVATION AND VAGOTOMY ON C-FOS EXPRESSION IN THE NUCLEUS-TRACTUS-SOLITARIUS AFTER EXPOSURE TO CO2
Authors: JANSEN AH NANCE DM LIU P WEISMAN H CHERNICK V
Citation: Ah. Jansen et al., EFFECT OF SINUS DENERVATION AND VAGOTOMY ON C-FOS EXPRESSION IN THE NUCLEUS-TRACTUS-SOLITARIUS AFTER EXPOSURE TO CO2, Pflugers Archiv, 431(6), 1996, pp. 876-881
A DOUBLE-BLIND TRIAL OF HALOPERIDOL, CHLORPROMAZINE, AND LORAZEPAM INTHE TREATMENT OF DELIRIUM IN HOSPITALIZED AIDS PATIENTS
Authors: BREITBART W MAROTTA R PLATT MM WEISMAN H DEREVENCO M GRAU C CORBERA K RAYMOND S LUND S JACOBSEN P
Citation: W. Breitbart et al., A DOUBLE-BLIND TRIAL OF HALOPERIDOL, CHLORPROMAZINE, AND LORAZEPAM INTHE TREATMENT OF DELIRIUM IN HOSPITALIZED AIDS PATIENTS, The American journal of psychiatry, 153(2), 1996, pp. 231-237
A CHIMERIC IGG4 MONOCLONAL-ANTIBODY DIRECTED AGAINST CD18 REDUCES INFARCT SIZE IN A PRIMATE MODEL OF MYOCARDIAL-ISCHEMIA AND REPERFUSION
Authors: AVERSANO T ZHOU W NEDELMAN M NAKADA M WEISMAN H
Citation: T. Aversano et al., A CHIMERIC IGG4 MONOCLONAL-ANTIBODY DIRECTED AGAINST CD18 REDUCES INFARCT SIZE IN A PRIMATE MODEL OF MYOCARDIAL-ISCHEMIA AND REPERFUSION, Journal of the American College of Cardiology, 25(3), 1995, pp. 781-788
UNTITLED
Authors: KEREIAKES D FERGUSON JJ POPMA JJ SHAW RE TCHENG JE WEISMAN H LINCOFF AM BREZINA K AGUIRRE F
Citation: D. Kereiakes et al., UNTITLED, The Journal of invasive cardiology, 6, 1994, pp. 10000043-10000056
EFFICACY OF NEUROLEPTICS FOR HYPOACTIVE DELIRIUM
Authors: PLATT MM BREITBART W SMITH M MAROTTA R WEISMAN H JACOBSEN PB
Citation: Mm. Platt et al., EFFICACY OF NEUROLEPTICS FOR HYPOACTIVE DELIRIUM, The Journal of neuropsychiatry and clinical neurosciences, 6(1), 1994, pp. 66-67
THE EFFECT OF THROMBIN RECEPTOR ACTIVATING PEPTIDE ON PLATELET-AGGREGATION IN PATIENTS UNDERGOING GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE WITH 7E3/
Authors: KLEIMAN NS JORDAN R COLLER B NORTON D WEISMAN H MERCADO C ROSE D TRAINOR K JOHNSON S BUSCHMANN L
Citation: Ns. Kleiman et al., THE EFFECT OF THROMBIN RECEPTOR ACTIVATING PEPTIDE ON PLATELET-AGGREGATION IN PATIENTS UNDERGOING GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE WITH 7E3/, Journal of the American College of Cardiology, 1994, pp. 10000063-10000063
RELATIONSHIP BETWEEN CORONARY-ARTERY CYCLIC FLOW VARIATIONS AFTER CORONARY ANGIOPLASTY IN HUMANS AND RECURRENT ISCHEMIC EVENTS - INITIAL OBSERVATIONS
Authors: ANDERSON HV KIRKEEIDE R BARADHI N JONES L KRISHNASWAMI A WEISMAN H WILLERSON J
Citation: Hv. Anderson et al., RELATIONSHIP BETWEEN CORONARY-ARTERY CYCLIC FLOW VARIATIONS AFTER CORONARY ANGIOPLASTY IN HUMANS AND RECURRENT ISCHEMIC EVENTS - INITIAL OBSERVATIONS, Journal of the American College of Cardiology, 1994, pp. 10000137-10000137
RANDOMIZED TRIAL OF CORONARY INTERVENTION WITH ANTIBODY AGAINST PLATELET IIB IIIA INTEGRIN FOR REDUCTION OF CLINICAL RESTENOSIS - RESULTS AT 6 MONTHS/
Authors: TOPOL EJ CALIFF RM WEISMAN HF ELLIS SG TCHENG JE WORLEY S IVANHOE R GEORGE BS FINTEL D WESTON M SIGMON K ANDERSON KM LEE KL WILLERSON JT SMITH CR WEISMAN H
Citation: Ej. Topol et al., RANDOMIZED TRIAL OF CORONARY INTERVENTION WITH ANTIBODY AGAINST PLATELET IIB IIIA INTEGRIN FOR REDUCTION OF CLINICAL RESTENOSIS - RESULTS AT 6 MONTHS/, Lancet, 343(8902), 1994, pp. 881-886
CHIMERIC 7E3 PREVENTS CAROTID-ARTERY THROMBOSIS IN CYNOMOLGUS MONKEYS
Authors: ROTE WE NEDELMAN MA MU DX MANLEY PJ WEISMAN H CUNNINGHAM MR LUCCHESI BR
Citation: We. Rote et al., CHIMERIC 7E3 PREVENTS CAROTID-ARTERY THROMBOSIS IN CYNOMOLGUS MONKEYS, Stroke, 25(6), 1994, pp. 1223-1232
USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY/
Authors: CALIFF RM SHADOFF N VALETT N BATES E GALEANA A KNOPF W SHAFTEL J BENDER MJ AVERSANO T RAQUENO J GURBEL P COWFER J COHEN M CROSS P BITTL J EDDINGS K TAYLOR M DEROSA K HATTEL L COOPER L ESHELMAN B FINTEL D NIEMYSKI P KLEIN L KENNEDY H THORNTON T KEREIAKES D MARTIN L ANDERSON L HIGBY N ELLIS S BREZINA K GEORGE B CHAPEKIS A SMITH D ANWAR A GERBER TL PRITCHARD GL MYLER R SHAW R MURPHY M WARD K MADIGAN NP BLANKENSHIP J HALBERT M FLANAGAN C TANNENBAUM M POLICH M STEVENSON C TCHENG J HOFFMAN S MOORE RM SMITH J HENRY P MCDONOUGH TJ WESZT S BRODIE B MUNCY D KLEIMAN N TRAINOR K ROSE D JOHNSON S WILLERSON J FERGUSON JJ HARLAN M BASS TA ROHMAN G BROWNE K CIESLA C WORLEY S TUZI J HETTLEMAN B BURKE WC OLSEN G KENNEDY SJ TALLEY JD YUSSMAN ZA RAWERT M GRASSMAN ED WRONA L SAMAHA J EHEMANN B BLEICH SD LEONHARD R CUMMINS F NONNWEILER J SANZ M MAYER D CLEMAN MW PASCALE VJ MCCONNELL S DELCORE M STENGEL L IVANHOE RJ GRANGER N ROSENBERG MJ SCHAECHTER A AYCOCK G WILCOX T GOTTLIEB R HUNTER H UNTERECKER W HART B HEUSER R HOOPMANN S HANOVICH G ANTOLICK A GACIOCH G CHIODO V KARSKI K TIMMIS G SAFIAN M AGUIRRE F STONNER T TAYLOR GJ WOMACK K RUYLE B KRAUTHAMER D WELCOM G WESTON M DILLON K FRENCH WJ REYNOLDS GT NAVETTA F MURPHY G LEBOEUF R SPENCER S POPMA JJ SWEET L TOPOL EJ SMITH CR WEISMAN H LEE KL MILLER J SIGMON K TCHENG J LEE KL LUI M KOSLOFF A DIFULVIO J WANG AL ANDERSON K WEISMAN H DANN R KINGMA W NORTON D MYER B MASEK R LEWANDOWSKI M BRODERICK S MUSCO M SCHORR M HARTMAN P MCCARDLE L FAXON D ARMSTRONG P GORE J LOSCALZO J MCCULLOUGH L VERTER J MARK DB DAVIDSONRAY L CLAPPCHANNING N LAM LC WAUGH RA MCCANTS CB HINDMAN MC DEHMER G HILLEGASS WB FRID DJ FORTIN DF BROTT BC FOREST TL UNKS DM HAMER ME WAGNER GS GATES K SANE D
Citation: Rm. Califf et al., USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY/, The New England journal of medicine, 330(14), 1994, pp. 956-961
INCREASED RISK OF NON-Q MI FOLLOWING DCA - EVIDENCE FOR A PLATELET DEPENDENT MECHANISM FROM THE EPIC TRIAL
Authors: LEFKOVITS J ANDERSON K WEISMAN H TOPOL EJ
Citation: J. Lefkovits et al., INCREASED RISK OF NON-Q MI FOLLOWING DCA - EVIDENCE FOR A PLATELET DEPENDENT MECHANISM FROM THE EPIC TRIAL, Circulation, 90(4), 1994, pp. 214-214
INCREASED RISK OF NON-Q MI FOLLOWING DCA - EVIDENCE FOR A PLATELET DEPENDENT MECHANISM FROM THE EPIC TRIAL
Authors: LEFKOVITS J ANDERSON K WEISMAN H TOPOL EJ
Citation: J. Lefkovits et al., INCREASED RISK OF NON-Q MI FOLLOWING DCA - EVIDENCE FOR A PLATELET DEPENDENT MECHANISM FROM THE EPIC TRIAL, Circulation, 90(4), 1994, pp. 214-214
PLATELET-IIB IIIA RECEPTOR INHIBITION DURING PTCA FOR ACUTE MYOCARDIAL-INFARCTION - INSIGHTS FROM THE EPIC TRIAL/
Authors: LEFKOVITS J IVANHOE R ANDERSON K WEISMAN H TOPOL EJ
Citation: J. Lefkovits et al., PLATELET-IIB IIIA RECEPTOR INHIBITION DURING PTCA FOR ACUTE MYOCARDIAL-INFARCTION - INSIGHTS FROM THE EPIC TRIAL/, Circulation, 90(4), 1994, pp. 564-564
PLATELET-IIB IIIA RECEPTOR INHIBITION DURING PTCA FOR ACUTE MYOCARDIAL-INFARCTION - INSIGHTS FROM THE EPIC TRIAL/
Authors: LEFKOVITS J IVANHOE R ANDERSON K WEISMAN H TOPOL EJ
Citation: J. Lefkovits et al., PLATELET-IIB IIIA RECEPTOR INHIBITION DURING PTCA FOR ACUTE MYOCARDIAL-INFARCTION - INSIGHTS FROM THE EPIC TRIAL/, Circulation, 90(4), 1994, pp. 564-564
DOES LENGTH OF THE CORONARY INTERVENTION PROCEDURE AFFECT EFFICACY OFPLATELET GLYCOPROTEIN-IIB GLYCOPROTEIN-IIIA BLOCKADE - RESULTS FROM THE EPIC TRIAL
Authors: OMOIGUI N LEFKOVITS J ELLIOTT J WEISMAN H
Citation: N. Omoigui et al., DOES LENGTH OF THE CORONARY INTERVENTION PROCEDURE AFFECT EFFICACY OFPLATELET GLYCOPROTEIN-IIB GLYCOPROTEIN-IIIA BLOCKADE - RESULTS FROM THE EPIC TRIAL, Circulation, 90(4), 1994, pp. 568-568
DOES LENGTH OF THE CORONARY INTERVENTION PROCEDURE AFFECT EFFICACY OFPLATELET GLYCOPROTEIN-IIB GLYCOPROTEIN-IIIA BLOCKADE - RESULTS FROM THE EPIC TRIAL
Authors: OMOIGUI N LEFKOVITS J ELLIOTT J WEISMAN H
Citation: N. Omoigui et al., DOES LENGTH OF THE CORONARY INTERVENTION PROCEDURE AFFECT EFFICACY OFPLATELET GLYCOPROTEIN-IIB GLYCOPROTEIN-IIIA BLOCKADE - RESULTS FROM THE EPIC TRIAL, Circulation, 90(4), 1994, pp. 568-568
HEPATIC BLOOD-VOLUME RESPONSES AND COMPLIANCE IN CATS WITH LONG-TERM BILE-DUCT LIGATION
Authors: SCHAFER J DALMEIDA MS WEISMAN H LAUTT WW
Citation: J. Schafer et al., HEPATIC BLOOD-VOLUME RESPONSES AND COMPLIANCE IN CATS WITH LONG-TERM BILE-DUCT LIGATION, Hepatology, 18(4), 1993, pp. 969-977
Risultati: 1-21 |